- INKT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
MiNK Therapeutics (INKT) S-1IPO registration
Filed: 13 Sep 21, 9:32pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 17, 2021, with respect to the consolidated financial statements of MiNK Therapeutics, Inc., included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
September 13, 2021
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.